Striving towards the elimination of HCV infection, Berlin 2018
EASL The Home of Hepatology
Archive
02.02.2018 - 03.02.2018Titanic Chaussee Berlin, Chausseestrasse 30, Berlin 10115, Germany
Time: 8:00 am to 4:30 pm
Conference themes Globally, morbidity and mortality due to HCV infection continues to rise. However, the availability of simple and tolerable DAA therapies for HCV infection with cure rates >90% is one of the greatest medical advances in decades. This has brought considerable optimism to people working in HCV. The WHO has set an ambitious goal to eliminate HCV as a major public health threat by 2030.
Professional congress organizer (PCO) Evvnt Promotion / evvnt
Notes Url:
Booking: https://go.evvnt.com/147888-1
Speakers: Prof. Francesco Negro, Dr. Alessio Aghemo, Prof. Jason Grebely